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Summary.-The proliferation characteristics of vascular endothelium have been
studied in 131 individual experimental tumours, representing 18 transplanted
tumour lines. The labelling index (LI) is high in most tumours, with a mean value
of 9.Oo%, regardless of the growth rate of the tumours, or whether different tumour
types are considered or individual tumours from within one line are studied in detail.
A similar high LI value has been found by others for a human tumour. These high LI
values may even underestimate the proliferation in new capillary buds. The high
proliferative index of tumour endothelium is in marked contrast with the previously
reported low 3HTdR uptake into normal tissue blood vessels. It seems likely that it
is the type of new vessels formed that will influence tumour growth rates more than
the simple rate of endothelial-cell proliferation. The large difference between the
proliferation characteristics of tumour endothelium and normal tissue endothelium,
recently identified as a possible approach for tumour therapy, has now been con-
firmed for a range of animal tumours and a human tumour.
THE VASCULAR NETWORK of tumours
has long been known to differ from normal
tissues, and to be inadequate in several
aspects (for relevant reviews see Petersen,
1979). Tumour blood vessels are less well
structured, more tortuous and permeable,
less innervated and spaced further apart
than the vessels in most normal tissues
(Egawa & Ishioka, 1979; Falk, 1978;
Gullino & Grantham, 1964; Hilmas &
Gillette, 1974; Mattson et al., 1979;
Reinhold, 1979; Rubin & Casarett, 1966;
Thomlinson & Gray, 1955; Vogel, 1965;
Warren 1979a, b). A wide variety of
of techniques has been used to study the
morphology (both qualitatively and quan-
titatively) and function of tumour blood
vessels (Peterson, 1979). These studies
have indicated a considerable hetero-
geneity of structure and function amongst
the individual vessels within 1 tumour, in
the same tumour at different sizes, and
amongst different tumours, whether of
the same histological type or of differing
histologies.
The disorganized vasculature oftumours
is generally believed to result from the
very rapid neovascularization that is
evoked in tumours by the endogenous
tumour angiogenesis factor, TAF (Folk-
man et al., 1971; Folkman & Cotran,
1976). In spite of the production of many
new vessels it is clear that vascular
inadequacy can limit the proliferation of
dependent tumour cells (Kligerman et
al., 1962; Tannock, 1968; Hirst & Dene-
kamp, 1979; Hirst et al., 1982). Tumour
cellsdistant from blood vessels are thought
to be radioresistant because of their
reduced oxygenation (Thomlinson & Gray,
1955), and chemoresistant because of
their nutritional deprivation.
In spite of the general interest in
tumour blood vessels there have been only
3 studies of the proliferation rate of their
component cells (Tannock, 1970; Gunduz,
1981; Hirst et al., 1982). The scarcity of
data probably results from the difficulty in
recognizing endothelial cells in tumours
because of the absence of endothelium-J. DENEKAMP AND B. HOBSON
specific stains. In addition, cyclic fluctua-
tions in blood flow through vessels may
result in an inhomogeneous distribution of
radioactive tracers, so that the prolifera-
tion may be heterogeneous in different
regions of the tumour (Tannock & Steel,
1969; Reinhold, 1979). Thus several limita-
tions ofthe kinetic parameters that can be
measured must be recognized at the
outset, especially that the average values
which can be obtained with standard
cell kinetic techniques may not give any
indication of regional variations. How-
ever, because of the shortage of informa-
tion in this area and the potential clinical
importance of such data (Denekamp,
1982) we have undertaken a study of
thymidine uptake into the endothelium
of a variety of different experimental
tumours. Tumours of widely different
growth rates have been studied and the
relationship between growth rate, tumour-
cell labelling and endothelial-cell labelling
has been investigated.
MATERIALS AND METHODS
The labelling experiments described in this
paper were performed over the period 1965-
81, but all the assessments of endothelial
labelling indices have been made in 1980-81.
Some of the details of tumour-cell prolifera-
tion have been published previously, but
generally without reference to the vascula-
ture. Table I lists the tumours in the order of
their growth rates, together with some infor-
mation about their origin, histology and
previous publications. In general the tumours
were transplanted s.c., by the simplest
technique possible, and were measured at
frequent intervals with Vernier calipers. At
the chosen size (usually 7-10 mm mean
diameter, unless otherwise stated) they were
labelled by giving a single i.p. injection of
0-5-1 ,Ci/g of low-specific activity tritiated
thymidine (0.36-1-0 HtCi/mol). The animals
were killed 0-5-2 h later; tumours were
removed, bisected for fixation in formol
saline, processed for histology and 4-5,um
sections were cut. Autoradiographs were
produced using Ilford K5 or Kodak NTB2
emulsion and were subsequently stained with
haematoxylin and eosin.
Blood vessels were identified under the
microscope'by the presence of red blood cells
in a space bounded by flattened endothelial
cells. The vessels were easier to identify in
carcinomata than in sarcomata, probably
because of the more obvious differences
between tumour and stromal cells in carcin-
omata, and possibly also because of a greater
degree of shrinkage of fibrosarcomata during
fixation. Two to eleven hundred endothelial
cells were counted in most tumours but in 7
of the 131 tumours <100 endothelial cells
could be identified. These were mainly the
small tumours listed in Table II. The diffi-
culty in finding large numbers of tumour
endothelial cells has prevented us from
classifying the vessels into different categor-
ies, either by size or position within the
tumour.
The labelling index (L.I.) of the tumour
cells was also scored by random scanning of
the tumour sections. Approximately 2000
tumour cells were counted for each LI
determination. A grain count of 3 grains
above background was set as the detection
limit for a labelled cell. Background levels
were generally <1 grain per cell-sized area.
RESULTS
One hundred and thirty-one individual
tumours have been assessed. For some
tumour types only 1 tumour has been
studied; for others up to 53 tumours have
been scored. Table I summarizes the
growth rates and the Lls of endothelial
cells and of tumour cells. The tumours
varied widely in growth rates, with
mean doubling times from 1 to 13 days.
The mean values and the standard error
(+ 1 s.e.) are indicated for the Lls where
more than 1 tumour was sampled. A 9-
fold range of mean LI values was observed
for the tumour cells (7.1-60.5%). The
range of LI values for endothelial cells
was similar but they were generally
lower (3 6-32 3%). The highest endo-
thelial LI (32.3%) was observed in the
sarcoma RIB5 in the Wistar rat, which
had a doubling time of 24 h. The lowest
mean endothelial LI was observed in the
equally fast-growing lymphoma KHAA,
but this was a tumour which grew by
invasion into the surrounding tissue as a
diffuse mass. rather than as a defined
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TABLE II.-Endothelial labelliny indices
in tumours of different sizes
Small tumours
(30-80 mm3)
Mea
Tumour
CA AD
CA BAC
CA TB
LI
(%)
12 8
16 7
18-0
6-0
8 2
18-6
10.9
11-4
15 6)
Mean
15 8
10-9
Large tumours
(230-410 mm3)
LI Mean
(%) (%)
4.4
14 5 12-5
18 5
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12 6 9-0
nodule. In this respect it differed from
all the other tumours. There is no obvious
trend in LI for either tumour cells or
endothelium with increasing volume-doub-
ling time (Table I).
These data are presented in more
detail in Figs. 1-4. Fig. 1 shows the mean
LI for the endothelial cells plotted as a
function of the mean volume-doubling
time, TD. Points without error bars
represent tumours in which only 1 sample
was studied. The error bars on other
points represent 1 s.e. An attempt has
been made to fit these data by regression
analysis of all the 131 individual values;
the correlation coefficient is low (r= 0 48).
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FiG. 1.-Tlhe labelling index of tumour
blood vessels plotted as a function of the
volume-doubling time of the tumours at
the size at killing (data from 131 tumours).
Points without errors represent single
tumour determinations. Error bars repre-
sent + 1 s.e. There is no significant correla-
tion (r= 0-48).
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FIG. 2.-The endothelial labelling index as a
function of the tumour-cell labelling index
for 89 tumours. Error bars represent 1 s.e.
There is less variability in endothelial LI
than in tumour-cell LI within each tumour
type. In general the endothelial LI values
are lower than those for tumour cells
(r=0.43).
A straight line clearly does not fit the
data well, particularly for tumours with
doubling times below 5 days. If the
endothelial LI values are plotted as a
function of the reciprocal of TD (i.e. the
rate of increase in tumour volume) a
slightly higher, but still poor, correlation
coefficient is obtained (r=0.71). This
demonstrates that the dependence of the
growthrateontheendothelialproliferation
is very weak in widely differing tumour
types.
Fig. 2 shows the endothelial LI values
plotted as a function of the tumour-cell
LI values. The dashed line represents
equality between these 2 parameters.
The endothelial LI values are generally
lower than the corresponding tumour-
cell LI values, indicating that endothelial
proliferation is generally slower than
tumour-cell proliferation. A linear regres-
sion analysis of the data, weighted
according to the number of tumours
contributing to each point, again gives
a very low correlation coefficient.
Figs 3 and 4 show a similar analysis
of the data obtained from the 2 tumours
which have been studied in most detail.
These are the moderately rapidly growing
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FIG. 3.-Endothelial LI as a function of volume-doubling times for (A) 33 individual CA SQ D
tumours (r= -0- 1) and for (B) 45 individual CA RH tumours (r= -0-17). There is no significant
correlation between these 2 parameters.
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FIG. 4.-Endothelial labelling index as a function of tumour-cell LI for (A) 20 individual CA SQ D
tumours (r=0-38) and for (B) 25 individual CA RH tumours (r=0.1). The endothelial LI values
are generally lower than those for the tumour cells and there is no correlation between them.
CA SQ D and the very slow-growing CA
RH. In these figures each point represents
the value for an individual tumour,
rather than the mean for a group of
similar tumours. Since the type of tumour
cell is now constant, correlations of endo-
48
thelial labelling with other parameters
should be more clearly distinguishable.
In Fig. 3 the endothelial LI values are
plotted against individual tumour volume-
doubling times, on the left for CA SQ D
and on the right for CA RH. The scales
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have been adjusted by a factor of 2 for
both axes since the faster growing CA
SQ D tumours also tend to have higher
values of endothelial LI. There is a wide
scatter in the data. Linear regression
analysis indicates very clearly that within
each tumour type there is no correlation
between these parameters (r= -0 0 and
- 0 17 respectively).
Fig. 4 shows the comparison of endo-
thelial and of tumour-cell LI values
within these 2 tumour types. The endo-
thelial LI values are generally much lower
than those for tumour cells, and most of
the data points fall well below the dashed
line which would indicate equality. The
data are widely scattered in each panel
and cannot be fitted by a linear regression
analysis; correlation coefficients are again
very low (r=0.38 and 0410). Clearly the
rate of tumour-cell proliferation in each
individual tumour is not directly related
to the rate of endothelial-cell proliferation
in the tumour blood vessels responsible
for supplying them with nutrients.
DISCUSSION
The data presented in this paper show
that the measured endothelial labelling
in tumours is generally high and is not
closely correlated with the tumour growth
rate, whether tumours of identical origin
or of widely differing histologies are
considered. Tumours seem to be capable
of evoking more or less rapid endothelial
proliferation, but this is not directly
related to the growth rate ofthe individual
tumours. It may relate to tumour-cell-
specific differences in the ability to pro-
duce tumour angiogenesis factor (TAF),
but we have no measurements of TAF to
support this.
The LI determinations have been made
in enlarged capillaries and sinusoids,
which may not be the most actively
proliferating regions in the tumour vascu-
lature and these values may therefore be
underestimates.
* Potential doubling time, T00t=ATs/LI where A is a
of cells through the cell cycle (Steel, 1968).
In the first kinetic study of vascular
endothelium. Tannock (1970) observed
that the LI of the endothelium was much
lower (11-4%) than the LI of the tumour
cells (350 ) and there was an even greater
discrepancy if only the tumour cells
adjacent to the capillary were counted
(LI = 500_) The rapid cell-cycle time
(13 h) and potential doubling time*
(22 h) of the tumour cells were contrasted
with the slower Tpot of the endothelial
cells (50-60 h). For 0 5 g tumours the
endothelial Tpot matched the volume-
doubling time of the tumours. He con-
cluded that "the rather different rates of
proliferation of parenchymal and stromal
cells may be a major cause of slowing of
tumour growth", although at larger sizes
he also implicated blood stasis as an
important factor. The contribution of
endothelial cells to the tumour vasculature
from an external, rapidly proliferating
pool of precursors was excluded on the
basis ofcontinuous labelling studies.
No further studies of the kinetics of
tumour vasculature were published until
the comprehensive study of lung metasta-
ses by Gunduz (1981). He measured the
cell kinetic parameters of tumour cells
and endothelium in small tumours (ranging
from 0 004 to 42 mm3) using many lung
nodules to obtain very large numbers of
endothelial cells (600-2000 per tumour).
This detailed study showed that endo-
thelial LI was independent of tumour
growth rate, i.e. similar to our present
results. In some tumours the endothelial
LI values were even higher than the
LI values for adjacent tumour cells. He
demonstrated that vascular proliferation
was more than adequate for tumour
growth, and was not the major reason
for development of areas of necrosis.
The vascular volume increased as the
tumours grew, but the proportion of
small "effective" capillaries fell from 990o
in small tumours to only 3800 in large
tumours.
Three of the tumours in the present
a correction factor for the non-uniform age distribution
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study were also assessed at 2 different
sizes: Both of them were large compared
with the lung metastases of Gunduz,
but they differed in volume by a factor of
about 8. These data are summarized
in Table II. The spread of values seems
to be wider in the large tumours, and the
mean value is consistently lower than in
the smaller tumours. This may represent
progressive failure of the nutrient supply,
even to the endothelial cells lining the
vessels in large tumours.
Hirst et al. (1982) studied the prolifera-
tion of tumour cells in 3 corded mammary
carcinomas and related the tumour
kinetics to the endothelial kinetics and to
the distance from the nearest capillary.
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FIG. 5.-The potential doubling time for the
endothelium has been calculated from
Tp0t=AT,/LI, using Ts=lO h and A=0-8.
This is plotte(d as a function of the tumour
volume-doubling time. The endothelial
proliferation can be 4 x faster (ratio 1:4)
or more than 4 x slower (4:1) than the
tumour doubling time. The wide scatter
indicates that these 2 parameters are
not correlated. G=published data of
Gunduz (1981); T =published data of
Tannock (1970). O=CA SQ D; *=CA
RH; * = mean values for other tumours
listed in Table I.
The endothelial LI ranged from 18% in
the faster growing tumours to 4.5% in
the slow-growing CA RH. The endothelial
turnover rate was much slower than the
potential doubling time of the tumour
cells but in each case was 2-4 times
faster than the tumour volume-doubling
time. The authors therefore concluded
that endothelial proliferation was inade-
quate but that vascular branching, as
opposed to simple elongation of existing
vessels, was a major limitation in the
growth of those tumours. The 3 tumours
are amongst those included in the present
study (see Table I).
The published data from Tannock (T)
and Gunduz (G) are summarized in
Fig. 5, together with the data from
Hirst et al. (1982) and the present study.
The potential doubling time for the
endothelium has been calculated and
plotted against the volume-doubling time
for each tumour type. A solid line has
been drawn to indicate equality between
endothelial Tpot and tumour TD. Several
points fall on this line, but most are
widely scattered about it, mainly falling
within the ratio 4:1 or 1:4. Thus the
endothelial turnover can be faster or
slower than the volume-doubling time.
Any attempt to correlate endothelial
proliferation with tumour volume-doubl-
ing time contains the implicit assumption
that all endothelial cells can be detected,
and that all labelled endothelial cells can
give rise to "effective" or useful vascula-
ture. However, neither of these assump-
tions has much experimental support.
Several authors (e.g. Falk, 1978; Gunduz,
1981; Hilmas & Gillette, 1974; Tannock,
1970; Tannock & Steel, 1969; Vogel, 1965;
Warren, 1979a) have indicated that with
increasing size the proportion of effective
vasculature in the tumour decreases. This
is illustrated schematically in Fig. 6.
Cell proliferation in the endothelium may
give rise to wider or longer individual
vessels in which the blood flow may be
slowed and/or the blood will become
depleted in nutrients. Furthermore, some
of the endothelial cells may be lost soon
n--
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RESULTS OF NEW ENDOTHELIAL CELL PRODUCTION
I i
ELONGATI ON
ENOOTHELIAL WIDENING
PROLIFERATION
CF[L LOSS
NEW SPROUTS
FiG. 6. Schematic (liagram to illustrate the
potential outcome of en(lotlhelial prolifera-
tion. Elongation or wideninig of existing
vessels will lead to less effective vasculature.
Onlv an increase in the 3-dimensional net-
work by new vessel sprouts an(d anasta-
moses will leadl to an increase in the
effective vasfulattire.
after they are produced, possibly by
mechanical damage resulting, from tur-
bulent blood flow. Cell loss has been
implicated in vessels in normal brain
(Korr et al., 1975) and in tumours (Hirst
et al., 1982).
Capillary budding (Ausprunk & Folk-
man, 1977) and subsequent anastomoses
of the buds is needed to increase the
capillary network in a 3-dimensional
array in order to increase the effective
vascular tree. Cells in non-functional
capillary buds may be missed in the pre-
sent study, since vessels were identified
by means of the erythrocytes contained
within them. Various authors have sug-
gested alternative stains for helping to
visualize the vessels e.g. Luxol Fast Blue
plus Periodic Acid-Schiff (Tannock, 1968)
but we were unable to obtain a better
definition in autoradiographs with this
stain than with conventional haematoxy-
lin and eosin. Non-functional capillary
buds extending into the tumour tissue are
unlikely to be identified without more
specific endothelial cell stains. These are
only just becoming available, with the
advent of specific monoclonal antibodies
to mouse endothelium (Ghandour et al.,
1982). Such buds may represent the most
important and possibly the most rapidly
proliferating elements in the vasculature
and attention will be focused on these
in future studies. Thus, the LI values
quoted here may be underestimates.
Unfortunately, with existing techniques
it is not possible to identify what propor-
tion of endothelial proliferation is con-
tributing to effective vasculature, and
this may explain the lack of correlation
between the 2 parameters in Fig. 5.
The present study, together with the
published data, indicate that prolifera-
tion of the vascular endothelium in
tumours can be very variable, but in
general the LI values are high, many of
them being in the range 10-20%. A
similar value (12-20%) has been found
for the endothelial LI in 2 regions of a
human parotid tumour after intra-arterial
administration of 3HTdR (Professor C.
Nervi, personal communication). Table
III summarizes the raw data from the
studies of Tannock (1970) and Gunduz
(19811). The individual LI values have
not previously been published, but have
been kindly provided by the authors.
These data, together with those from
the tumours we studied, are included in
histogram format in Fig. 7. The mean
20
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TABLE III.-Endothelial labelling indices in C3H mammary carcinomas
Tumour size Individual labelling Mean
Author (mm3) index values + 1 s.e.
Tannock 500 a7, 8, 8, 9, 9, 13, 13, 11-4
(1970) 15, 15, 17
Gunduz
(1981) 0 004 b12.9, 14-2, 14-4, 14-5
14-5, 14-7, 16-4 +0 5
(1981) 0 033 b8-3, 10-7, 11-0, 13-4
14-1, 17-1, 19-0 +1-7
(1981) 0-269 b9-0, 121, 13-3 14-0
15-2, 17-0, 17-6 +1-3
(1981) 0-525 b9l-, 11-8, 12-5, 13-5
14-7, 16-2, 16-5 +1-2
(1981) 1-772 b8-9, 118, 13-7, 14-5
16-5, 17-6, 18-0 +1-5
(1981) 4-200 bll-3, 11-4, 12-7, 13-8
15-3, 16-0, 16-2 +0 9
a Previously unpublished as raw data; kindly provided bv Dr I. Tannock. Each estimate is derived from
counts of 100 endothelial cells.
b Previously unpublished as raw data; kindly provided by Dr N, Gunduz. Each estimate is derived from
counts of 630-2010 endothelial cells.
LI for all these tumours is 9.0%, and the
median value 7-8%. This is in marked
contrast to the very low LI in normal
tissue endothelium (median LI=0.22%;
see summaries by Hirst et al., 1979;
Denekamp, 1982). This 35-fold difference
has recently been highlighted as a poten-
tial new route for attacking tumours
by means of antibody-toxin conjugates
or intravascularly retained cycle-specific
cytotoxic drugs (Denekamp, 1982). It
could also provide a means for diagnosing
any small micrometastases which have
evoked a neovasculature, using radioiso-
topes and imaging techniques. The present
large body of data confirms that the
LI values are high in almost all tumours
studied regardless of their growth rates.
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